Affinivax
Vaccine Discovery Technology Affinivax is a biopharmaceutical company developing vaccines that target infectious diseases.
3
Funding Rounds
$348.5m
Money raised
Overview
Vaccine Discovery Technology Affinivax is a biopharmaceutical company developing vaccines that target infectious diseases.
- Website:
- Business model: B2B
- Headquarters: Cambridge, Massachusetts
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ka**** Ta****** | - | - | - |
| Fa* Zh**** Ph* | - | - | - |
| Ri***** Ma***** MD | - | - | - |
| Yi***** Lu* Ph* | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Affinivax has raised a total of $122.5m in funding over 3 rounds.
Key Insights:
- Affinivax Series B round, April 2020: $120m
- Affinivax Series A round, February 2016: $2.5m
- Affinivax, Inc. funding round, January 2021: $226m
Affinivax Series B round, April 2020
$120m
Affinivax Series A round, February 2016
$2.5m
Affinivax, Inc. funding round, January 2021
$226m
Industries
Affinivax is active in the following industries:
- Engineering
- Vaccine
- Biomedical engineering
- Technology
- Biology
- Biotechnology
- Healthcare